Project 1 - Virus-Host Interactions in Gammaherpesvirus Pathogenesis

项目 1 - 伽玛疱疹病毒发病机制中的病毒-宿主相互作用

基本信息

项目摘要

The human gammaherpesviruses (GHVs) Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) are DNA tumor viruses that establish lifelong chronic infections of host lymphocytes and other cell types. Through the expression of viral gene products that alter normal cellular signaling pathways and counteract host immune responses, GHVs place the chronically infected host at risk for numerous malignancies. As it relates to the COBRE theme of defining the impact of microbial virulence factors on host inflammatory and immune responses, the overall objective of experiments described in this project is to better define mechanisms by which GHVs counteract innate host defense mechanisms in order to successfully colonize a host. Central to this objective is the utilization of murine gammaherpesvirus-68 (MHV68), a naturally occurring rodent pathogen that is genetically related to EBV and KSHV and recapitulates key aspects of human GHV infection as a tractable small-animal model to define the virus-host interaction in vivo. Extending our published and preliminary data, the current proposal specifically seeks to understand functions of the MHV68 latency-associated nuclear antigen (mLANA), a putative viral transcriptional repressor protein, as a critical modulator of antiviral transcriptional pathways or cellular immune responses activated by interferon alpha/Beta (IFN-I) signaling that would otherwise restrict GHV infection. This work will be accomplished in three integrated but independent specific aims: (1) define IFN-l-mediated control of GHV infection at mucosal barriers, (2) elucidate roles for mLANA-mediated transcriptional control in MHV68 pathogenesis, and (3) define mLANA-interferon regulatory factor 3 (IRF-3) interactions in MHV68 infection. The proposed experiments hold broad significance by addressing two critical gaps in our understanding of GHV pathogenesis: the functions of viral disease determinants in the success of GHV infection and the interactions of GHV with host innate immune response pathways. Moreover, by advancing understanding of the nature of host immune responses, which is fundamentally important to all infectious diseases, the proposed experiments may also hold relevance for diseases caused by diverse and unrelated intracellular pathogens.
人类γ疱疹病毒(GHV)、EB病毒(EBV)和卡波西肉瘤相关疱疹病毒(KSHV)是DNA肿瘤病毒,其建立宿主淋巴细胞和其他细胞类型的终身慢性感染。通过病毒基因产物的表达,改变正常的细胞信号传导途径和抵消宿主的免疫反应,GHV将慢性感染的宿主置于许多恶性肿瘤的风险中。由于它涉及到定义微生物毒力因子对宿主炎症和免疫反应的影响的COBRE主题,本项目中描述的实验的总体目标是更好地定义GHV抵消先天宿主防御机制的机制,以便成功地定殖宿主。这一目标的核心是利用鼠γ疱疹病毒-68(MHV 68),一种天然存在的啮齿动物病原体,与EBV和KSHV遗传相关,并概括了人类GHV感染的关键方面,作为一种易于处理的小动物模型,以确定体内病毒-宿主相互作用。扩展我们已发表的和初步的数据,目前的建议,特别是寻求了解功能的MHV 68潜伏相关的核抗原(mLANA),一个假定的病毒转录抑制蛋白,作为抗病毒转录途径或细胞免疫反应的关键调制器激活的干扰素α/β(IFN-I)信号,否则会限制GHV感染。这项工作将在三个整合但独立的具体目标中完成:(1)定义IFN-1介导的对粘膜屏障处GHV感染的控制,(2)阐明mLANA介导的转录控制在MHV 68发病机制中的作用,和(3)定义mLANA-干扰素调节因子3(IRF-3)在MHV 68感染中的相互作用。拟议的实验具有广泛的意义,通过解决我们对GHV发病机制的理解中的两个关键差距:病毒疾病决定因素在GHV感染成功中的作用以及GHV与宿主先天免疫应答途径的相互作用。此外,通过推进对宿主免疫反应性质的理解,这对所有感染性疾病都至关重要,所提出的实验也可能与由不同和不相关的细胞内病原体引起的疾病相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Craig Forrest其他文献

James Craig Forrest的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Craig Forrest', 18)}}的其他基金

Defining mechanisms of KSHV pathogenesis using MHV68-KSHV chimeric viruses
使用 MHV68-KSHV 嵌合病毒定义 KSHV 发病机制
  • 批准号:
    10243300
  • 财政年份:
    2020
  • 资助金额:
    $ 32.95万
  • 项目类别:
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients
牙周细菌增强 HIV 患者口腔 KSHV 发病机制和卡波西肉瘤的发展
  • 批准号:
    10015211
  • 财政年份:
    2019
  • 资助金额:
    $ 32.95万
  • 项目类别:
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients
牙周细菌增强 HIV 患者口腔 KSHV 发病机制和卡波西肉瘤的发展
  • 批准号:
    10400690
  • 财政年份:
    2019
  • 资助金额:
    $ 32.95万
  • 项目类别:
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients
牙周细菌增强 HIV 患者口腔 KSHV 发病机制和卡波西肉瘤的发展
  • 批准号:
    10613370
  • 财政年份:
    2019
  • 资助金额:
    $ 32.95万
  • 项目类别:
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells
定义 B 细胞中伽马疱疹病毒驱动的基因组不稳定性的机制
  • 批准号:
    10467371
  • 财政年份:
    2014
  • 资助金额:
    $ 32.95万
  • 项目类别:
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells
定义 B 细胞中伽马疱疹病毒驱动的基因组不稳定性的机制
  • 批准号:
    10590669
  • 财政年份:
    2014
  • 资助金额:
    $ 32.95万
  • 项目类别:
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells
定义 B 细胞中伽马疱疹病毒驱动的基因组不稳定性的机制
  • 批准号:
    10747707
  • 财政年份:
    2014
  • 资助金额:
    $ 32.95万
  • 项目类别:
Gammaherpesvirus interactions with host tumor suppressor p53
伽马疱疹病毒与宿主肿瘤抑制因子 p53 的相互作用
  • 批准号:
    9213350
  • 财政年份:
    2014
  • 资助金额:
    $ 32.95万
  • 项目类别:
Gammaherpesvirus interactions with host tumor suppressor p53
伽马疱疹病毒与宿主肿瘤抑制因子 p53 的相互作用
  • 批准号:
    8696558
  • 财政年份:
    2014
  • 资助金额:
    $ 32.95万
  • 项目类别:
DETERMINANTS OF CHRONIC GAMMAHERPESVIRUS 68 INFECTION
慢性丙型疱疹病毒 68 感染的决定因素
  • 批准号:
    7349299
  • 财政年份:
    2006
  • 资助金额:
    $ 32.95万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 32.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了